{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:03:00Z","timestamp":1794362580321,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cancer cells have an imbalance in oxidation-reduction (redox) homeostasis. Understanding the precise mechanisms and the impact of the altered redox microenvironment on the immunologic reaction to tumors is limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We isolated exosomes from ovarian cancer cells through ultracentrifuge and characterized by Western-blots and Nanoparticle Tracking Analysis. 2D, 3D-coculture tumor model, and 3D live cell imaging were used to study the interactions between tumor cells, macrophages and CD3 T cells in vitro. The role of exosomal miR-155-5p in tumor growth was evaluated in xenograft nude mice models and immune-competent mice models. Flow cytometry and flow sorting were used to determine the expression levels of miR-155-5p and PD-L1 in ascites and splenic macrophages, and the percentages of CD3 T cells subpopulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The elevation of reactive oxygen species (ROS) greatly downregulated exosomal miR-155-5p expression in tumor cells. Neutralization of ROS with N-acetyl-L-cysteine (NAC) increased the levels of miR-155-5p in tumor exosomes that were taken up by macrophages, leading to reduction of macrophage migration and tumor spheroid infiltration. We further found that programmed death ligand 1 (PD-L1) is a functional target of miR-155-5p. Co-culture of macrophages pre-treated with NAC-derived tumor exosomes or exosomal miR-155-5p with T-lymphocytes leading to an increased percentage of CD8<jats:sup>+<\/jats:sup>T-lymphocyte and a decreased CD3<jats:sup>+<\/jats:sup>T cell apoptosis through PD-L1 downregulation. Tumor growth in nude mice was delayed by treatment with NAC-derived tumor exosomes. Delivery of tumor exo-miR-155-5p in immune-intact mice suppressed ovarian cancer progression and macrophage infiltration, and activated CD8<jats:sup>+<\/jats:sup>T cell function. It is of note that exo-miR-155-5p inhibited tumor growth more potently than the PD-L1 antibody, suggesting that in addition to PD-L1, other pathways may also be targeted by this approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings demonstrate a novel mechanism, ROS-induced down-regulation of miR-155-5p, by which tumors modulate the microenvironment that favors tumor growth. Understanding of the negative impact of ROS on the tumor immune response will improve current therapeutic strategies. Targeting miR-155-5p can be an alternative approach to prevent formation of an immunosuppressive TME through downregulation of PD-L1 and other immunosuppressive factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s13046-022-02244-1","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T08:03:03Z","timestamp":1643270583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p\/PD-L1 pathway"],"prefix":"10.1186","volume":"41","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Peiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u1ef9 G.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Aplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5162-6041","authenticated-orcid":false,"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"1","key":"2244_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2244_CR2","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/ijc.30676","volume":"140","author":"SB Coburn","year":"2017","unstructured":"Coburn SB, Bray F, Sherman ME, Trabert B. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer. 2017;140(11):2451\u201360.","journal-title":"Int J Cancer"},{"issue":"1","key":"2244_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/annonc\/mdv500","volume":"27","author":"KS Tewari","year":"2016","unstructured":"Tewari KS, Java JJ, Eskander RN, Monk BJ, Burger RA. Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG oncology\/gynecologic oncology group study. Ann Oncol. 2016;27(1):114\u201321.","journal-title":"Ann Oncol"},{"key":"2244_CR4","doi-asserted-by":"crossref","unstructured":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet (London, England). 2002;360(9332):505\u201315.","DOI":"10.1016\/S0140-6736(02)09738-6"},{"key":"2244_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256.","journal-title":"Front Oncol"},{"issue":"10","key":"2244_CR6","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1111\/j.1349-7006.2010.01652.x","volume":"101","author":"K Takaishi","year":"2010","unstructured":"Takaishi K, Komohara Y, Tashiro H, Ohtake H, Nakagawa T, Katabuchi H, et al. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation. Cancer Sci. 2010;101(10):2128\u201336.","journal-title":"Cancer Sci"},{"key":"2244_CR7","doi-asserted-by":"publisher","first-page":"106471","DOI":"10.1016\/j.intimp.2020.106471","volume":"84","author":"Y Yousefzadeh","year":"2020","unstructured":"Yousefzadeh Y, Hallaj S, Baghi Moornani M, Asghary A, Azizi G, Hojjat-Farsangi M, et al. Tumor associated macrophages in the molecular pathogenesis of ovarian cancer. Int Immunopharmacol. 2020;84:106471.","journal-title":"Int Immunopharmacol"},{"key":"2244_CR8","doi-asserted-by":"publisher","first-page":"179486","DOI":"10.1155\/2014\/179486","volume":"2014","author":"C Roma-Rodrigues","year":"2014","unstructured":"Roma-Rodrigues C, Fernandes AR, Baptista PV. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed Res Int. 2014;2014:179486.","journal-title":"Biomed Res Int"},{"issue":"4","key":"2244_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI81130","volume":"126","author":"N Kosaka","year":"2016","unstructured":"Kosaka N, Yoshioka Y, Fujita Y, Ochiya T. Versatile roles of extracellular vesicles in cancer. J Clin Invest. 2016;126(4):1163\u201372.","journal-title":"J Clin Invest"},{"issue":"1","key":"2244_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.","journal-title":"Mol Cancer"},{"key":"2244_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1201\/9781315392349","volume-title":"Advances in Clinical Chemistry","author":"TL Whiteside","year":"2016","unstructured":"Whiteside TL. Chapter Four - Tumor-Derived Exosomes and Their Role in Cancer Progression. In: Makowski GS, editor. Advances in Clinical Chemistry, vol. 74: Elsevier; 2016. p. 103\u201341."},{"issue":"12","key":"2244_CR12","doi-asserted-by":"publisher","first-page":"e15353","DOI":"10.1371\/journal.pone.0015353","volume":"5","author":"M Eldh","year":"2010","unstructured":"Eldh M, Ekstr\u00f6m K, Valadi H, Sj\u00f6strand M, Olsson B, Jern\u00e5s M, et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One. 2010;5(12):e15353.","journal-title":"PLoS One"},{"issue":"22","key":"2244_CR13","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","volume":"67","author":"C Xia","year":"2007","unstructured":"Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007;67(22):10823\u201330.","journal-title":"Cancer Res"},{"issue":"2","key":"2244_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s40495-016-0051-4","volume":"2","author":"J He","year":"2016","unstructured":"He J, Jiang BH. Interplay between reactive oxygen species and MicroRNAs in Cancer. Curr Pharmacol Rep. 2016;2(2):82\u201390.","journal-title":"Curr Pharmacol Rep"},{"key":"2244_CR15","doi-asserted-by":"publisher","first-page":"2415324","DOI":"10.1155\/2020\/2415324","volume":"2020","author":"C Lu","year":"2020","unstructured":"Lu C, Zhou D, Wang Q, Liu W, Yu F, Wu F, et al. Crosstalk of MicroRNAs and oxidative stress in the pathogenesis of Cancer. Oxidative Med Cell Longev. 2020;2020:2415324.","journal-title":"Oxidative Med Cell Longev"},{"issue":"4","key":"2244_CR16","first-page":"5561","volume":"15","author":"J Liu","year":"2018","unstructured":"Liu J, Chen Z, Xiang J, Gu X. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro. Oncol Lett. 2018;15(4):5561\u20138.","journal-title":"Oncol Lett"},{"issue":"6","key":"2244_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-18-0504","volume":"7","author":"A Martinez-Usatorre","year":"2019","unstructured":"Martinez-Usatorre A, Sempere LF, Carmona SJ, Carretero-Iglesia L, Monnot G, Speiser DE, et al. MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma. Cancer Immunol Res. 2019;7(6):1013.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2244_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08830180903093796","volume":"28","author":"E Tili","year":"2009","unstructured":"Tili E, Croce CM, Michaille J-J. miR-155: on the crosstalk between inflammation and Cancer. Int Rev Immunol. 2009;28(5):264\u201384.","journal-title":"Int Rev Immunol"},{"issue":"4","key":"2244_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neo.2017.02.001","volume":"19","author":"S Yadav","year":"2017","unstructured":"Yadav S, Singh N, Shah PP, Rowbotham DA, Malik D, Srivastav A, et al. MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis. Neoplasia (New York, NY). 2017;19(4):321\u201332.","journal-title":"Neoplasia (New York, NY)"},{"issue":"7","key":"2244_CR20","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1007\/s13277-016-4804-9","volume":"37","author":"W Chen","year":"2016","unstructured":"Chen W, Huang L, Hao C, Zeng W, Luo X, Li X, et al. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells. Tumour Biol. 2016;37(7):9289\u201399.","journal-title":"Tumour Biol"},{"issue":"50","key":"2244_CR21","doi-asserted-by":"publisher","first-page":"20683","DOI":"10.1074\/jbc.M117.809053","volume":"292","author":"D Yee","year":"2017","unstructured":"Yee D, Shah KM, Coles MC, Sharp TV, Lagos D. MicroRNA-155 induction via TNF-alpha and IFN-gamma suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells. J Biol Chem. 2017;292(50):20683\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"2244_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","volume":"18","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, et al. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Mol Cancer. 2019;18(1):54.","journal-title":"Mol Cancer"},{"issue":"12","key":"2244_CR23","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.3390\/ijms18122540","volume":"18","author":"Q Wang","year":"2017","unstructured":"Wang Q, Lin W, Tang X, Li S, Guo L, Lin Y, et al. The roles of microRNAs in regulating the expression of PD-1\/PD-L1 immune checkpoint. Int J Mol Sci. 2017;18(12):2540.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2244_CR24","doi-asserted-by":"publisher","first-page":"28125","DOI":"10.18632\/oncotarget.15924","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wang D, Xie G, Yin Y, Zhao E, Tao K, et al. MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma. Oncotarget. 2017;8(17):28125\u201334.","journal-title":"Oncotarget"},{"issue":"1","key":"2244_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39\u201351.","journal-title":"Cell"},{"issue":"1","key":"2244_CR26","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/s41467-019-10979-3","volume":"10","author":"M Czystowska-Kuzmicz","year":"2019","unstructured":"Czystowska-Kuzmicz M, Sosnowska A, Nowis D, Ramji K, Szajnik M, Chlebowska-Tuz J, et al. Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun. 2019;10(1):3000.","journal-title":"Nat Commun"},{"issue":"9","key":"2244_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1089\/ars.2017.7276","volume":"29","author":"MS Leisegang","year":"2018","unstructured":"Leisegang MS, Schr\u00f6der K, Brandes RP. Redox regulation and noncoding RNAs. Antioxid Redox Signal. 2018;29(9):793\u2013812.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2244_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2015.07.008","volume":"367","author":"L Tong","year":"2015","unstructured":"Tong L, Chuang CC, Wu S, Zuo L. Reactive oxygen species in redox cancer therapy. Cancer Lett. 2015;367(1):18\u201325.","journal-title":"Cancer Lett"},{"issue":"12","key":"2244_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/ars.2012.4617","volume":"19","author":"X Lin","year":"2013","unstructured":"Lin X, Zheng W, Liu J, Zhang Y, Qin H, Wu H, et al. Oxidative stress in malignant melanoma enhances tumor necrosis factor-\u03b1 secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal. 2013;19(12):1337\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"2244_CR30","doi-asserted-by":"crossref","unstructured":"Weinberg F, Ramnath N, Nagrath D. Reactive oxygen species in the tumor microenvironment: an overview. Cancers (Basel). 2019;11(8).","DOI":"10.3390\/cancers11081191"},{"issue":"41","key":"2244_CR31","doi-asserted-by":"publisher","first-page":"17686","DOI":"10.1073\/pnas.1012016107","volume":"107","author":"MD Kraaij","year":"2010","unstructured":"Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A. 2010;107(41):17686\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2244_CR32","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","volume":"80","author":"K Ford","year":"2020","unstructured":"Ford K, Hanley CJ, Mellone M, Szyndralewiez C, Heitz F, Wiesel P, et al. NOX4 inhibition potentiates immunotherapy by overcoming Cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors. Cancer Res. 2020;80(9):1846\u201360.","journal-title":"Cancer Res"},{"issue":"3","key":"2244_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/cam4.1355","volume":"7","author":"M Wang","year":"2018","unstructured":"Wang M, Yang F, Qiu R, Zhu M, Zhang H, Xu W, et al. The role of mmu-miR-155-5p-NF-\u03baB signaling in the education of bone marrow-derived mesenchymal stem cells by gastric cancer cells. Cancer Med. 2018;7(3):856\u201368.","journal-title":"Cancer Med"},{"issue":"221","key":"2244_CR34","doi-asserted-by":"publisher","first-page":"221ra215","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6(221):221ra215.","journal-title":"Sci Transl Med"},{"issue":"12","key":"2244_CR35","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/embor.2012.162","volume":"13","author":"J He","year":"2012","unstructured":"He J, Xu Q, Jing Y, Agani F, Qian X, Carpenter R, et al. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a\/125b and DNA methylation. EMBO Rep. 2012;13(12):1116\u201322.","journal-title":"EMBO Rep"},{"issue":"15","key":"2244_CR36","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/emboj\/cdg379","volume":"22","author":"S Sakon","year":"2003","unstructured":"Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 2003;22(15):3898\u2013909.","journal-title":"EMBO J"},{"issue":"26","key":"2244_CR37","doi-asserted-by":"publisher","first-page":"15703","DOI":"10.1074\/jbc.271.26.15703","volume":"271","author":"YY Lo","year":"1996","unstructured":"Lo YY, Wong JM, Cruz TF. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem. 1996;271(26):15703\u20137.","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"2244_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/ars.2005.7.395","volume":"7","author":"Y Kabe","year":"2005","unstructured":"Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal. 2005;7(3\u20134):395\u2013403.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2244_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu Z-G. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res. 2011;21(1):103\u201315.","journal-title":"Cell Res"},{"issue":"1","key":"2244_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86.","journal-title":"Mol Cancer"},{"key":"2244_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fonc.2014.00137","volume":"4","author":"EK Colvin","year":"2014","unstructured":"Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol. 2014;4:137.","journal-title":"Front Oncol"},{"issue":"1","key":"2244_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","volume":"147","author":"X Yuan","year":"2017","unstructured":"Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W, et al. Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis. Gynecol Oncol. 2017;147(1):181\u20137.","journal-title":"Gynecol Oncol"},{"issue":"28","key":"2244_CR43","doi-asserted-by":"publisher","first-page":"43076","DOI":"10.18632\/oncotarget.9246","volume":"7","author":"X Ying","year":"2016","unstructured":"Ying X, Wu Q, Wu X, Zhu Q, Wang X, Jiang L, et al. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget. 2016;7(28):43076\u201387.","journal-title":"Oncotarget"},{"issue":"1","key":"2244_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3892\/or.2017.5697","volume":"38","author":"X Chen","year":"2017","unstructured":"Chen X, Ying X, Wang X, Wu X, Zhu Q, Wang X. Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization. Oncol Rep. 2017;38(1):522\u20138.","journal-title":"Oncol Rep"},{"issue":"1","key":"2244_CR45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.30607","volume":"70","author":"J Liu","year":"2019","unstructured":"Liu J, Fan L, Yu H, Zhang J, He Y, Feng D, et al. Endoplasmic reticulum stress causes liver Cancer cells to release Exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology. 2019;70(1):241\u201358.","journal-title":"Hepatology"},{"issue":"2","key":"2244_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1172\/JCI96113","volume":"128","author":"H Lin","year":"2018","unstructured":"Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J Clin Invest. 2018;128(2):805\u201315.","journal-title":"J Clin Invest"},{"key":"2244_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gore.2019.06.003","volume":"29","author":"DW Doo","year":"2019","unstructured":"Doo DW, Norian LA, Arend RC. Checkpoint inhibitors in ovarian cancer: a review of preclinical data. Gynecol Oncol Rep. 2019;29:48\u201354.","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"2244_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ygyno.2016.04.002","volume":"142","author":"X Zhu","year":"2016","unstructured":"Zhu X, Lang J. The significance and therapeutic potential of PD-1 and its ligands in ovarian cancer: a systematic review. Gynecol Oncol. 2016;142(1):184\u20139.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2244_CR49","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.4049\/jimmunol.1100274","volume":"186","author":"J Krempski","year":"2011","unstructured":"Krempski J, Karyampudi L, Behrens MD, Erskine CL, Hartmann L, Dong H, et al. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer. J Immunol (Baltimore, Md : 1950). 2011;186(12):6905\u201313.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"12","key":"2244_CR50","doi-asserted-by":"publisher","first-page":"e84927","DOI":"10.1371\/journal.pone.0084927","volume":"8","author":"H Wei","year":"2013","unstructured":"Wei H, Zhao L, Li W, Fan K, Qian W, Hou S, et al. Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine Cancer models and synergizes with cisplatin. PLoS One. 2013;8(12):e84927.","journal-title":"PLoS One"},{"issue":"2","key":"2244_CR51","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/ar4531","volume":"16","author":"HM Jin","year":"2014","unstructured":"Jin HM, Kim TJ, Choi JH, Kim MJ, Cho YN, Nam KI, et al. MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Arthritis Res Therapy. 2014;16(2):R88.","journal-title":"Arthritis Res Therapy"},{"issue":"27","key":"2244_CR52","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011;108(27):11193\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2244_CR53","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2012.12.006","volume":"38","author":"JC Dudda","year":"2013","unstructured":"Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity. 2013;38(4):742\u201353.","journal-title":"Immunity"},{"issue":"12","key":"2244_CR54","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1073\/pnas.1101795108","volume":"108","author":"E Tili","year":"2011","unstructured":"Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A. 2011;108(12):4908\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2244_CR55","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.0902636106","volume":"106","author":"RM O'Connell","year":"2009","unstructured":"O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009;106(17):7113\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2244_CR56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/gcc.22698","volume":"58","author":"JJ Michaille","year":"2019","unstructured":"Michaille JJ, Awad H, Fortman EC, Efanov AA, Tili E. miR-155 expression in antitumor immunity: the higher the better? Genes Chromosom Cancer. 2019;58(4):208\u201318.","journal-title":"Genes Chromosom Cancer"},{"issue":"1\u20132","key":"2244_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijpharm.2018.08.040","volume":"550","author":"M Lu","year":"2018","unstructured":"Lu M, Zhao X, Xing H, Xun Z, Zhu S, Lang L, et al. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int J Pharm. 2018;550(1\u20132):100\u201313.","journal-title":"Int J Pharm"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T09:54:49Z","timestamp":1700128489000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02244-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimental protocols were in consistent with the Care and Use of Laboratory Animals Guide and approved by the Institutional Animal Care & Use Committee of Thomas Jefferson University (No. 01159).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors have read and approved of its submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}